Story perspectives
GLP-1 Medications Transform U.S. Dining Trends Dramatically
10/20/2025
31 7
1 of 1
Story summary
- The rise of glucagon-like peptide-1 (GLP-1) medications such as Ozempic and Wegovy is reshaping dining habits in the United States.
- About 10–12% of Americans use these drugs.
- Usage has grown about 600% since 2019.
- Clinton Hall restaurant has introduced mini meals to cater to changing appetites.
- Restaurateurs are emphasizing ambiance and overall dining experiences to engage customers.
